Cathepsin S signals via PAR2 and generates a novel tethered ligand receptor agonist

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Elmariah, Sarina B ^a   Reddy, Vemuri B ^a   Lerner, Ethan A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN S; HEXAPEPTIDE; LYSYLVALYLASPARTYLGLYCYLTHREONYLSERINE; PROTEINASE ACTIVATED RECEPTOR 2; UNCLASSIFIED DRUG; CATHEPSIN;

AMINO TERMINAL SEQUENCE; ARTICLE; ATTENUATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME MODIFICATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; KERATINOCYTE; NEWBORN; POINT MUTATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUBSTITUTION REACTION; AMINO ACID SEQUENCE; CHEMISTRY; GENETICS; HELA CELL LINE; METABOLISM; PHYSIOLOGY; PROTEIN ANALYSIS;

AMINO ACID SEQUENCE; CATHEPSINS; HELA CELLS; HUMANS; KERATINOCYTES; PROTEIN INTERACTION MAPPING; RECEPTOR, PAR-2; SIGNAL TRANSDUCTION;

EID: 84903535823     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099702     Document Type: Article

References (38)

1. Coughlin SR (2005) Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3: 1800-1814.
2. Aikawa E, Aikawa M, Libby P, Figueiredo JL, Rusanescu G, et al. (2009) Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation 119: 1785-1794.
3. Moormann C, Artuc M, Pohl E, Varga G, Buddenkotte J, et al. (2006) Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells. J Invest Dermatol 126: 746-755.
4. Briot A, Deraison C, Lacroix M, Bonnart C, Robin A, et al. (2009) Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 206: 1135-1147.
5. Reddy VB, Shimada SG, Sikand P, Lamotte RH, Lerner EA (2010) Cathepsin S elicits itch and signals via protease-activated receptors. J Invest Dermatol 130: 1468-1470.
6. Jeong SK, Kim HJ, Youm JK, Ahn SK, Choi EH, et al. (2008) Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. J Invest Dermatol 128: 1930-1939. (Pubitemid 352001196)
7. Lourbakos A, Chinni C, Thompson P, Potempa J, Travis J, et al. (1998) Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett 435: 45-48. (Pubitemid 28432012)
8. Reddy VB, Lerner EA (2010) Plant cysteine proteases that evoke itch activate protease-activated receptors. Br J Dermatol 163: 532-535.
9. Vu TK, Hung DT, Wheaton VI, Coughlin SR (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 1057-1068. (Pubitemid 121001193)
10. Vu TK, Wheaton VI, Hung DT, Charo I, Coughlin SR (1991) Domains specifying thrombin-receptor interaction. Nature 353: 674-677. (Pubitemid 21912589)
11. Chen YH, Pouyssegur J, Courtneidge SA, Van Obberghen-Schilling E (1994) Activation of Src family kinase activity by the G protein-coupled thrombin receptor in growth-responsive fibroblasts. J Biol Chem 269: 27372-27377. (Pubitemid 24346561)
12. Lerner DJ, Chen M, Tram T, Coughlin SR (1996) Agonist recognition by proteinase-activated receptor 2 and thrombin receptor. Importance of extracellular loop interactions for receptor function. J Biol Chem 271: 13943-13947.
13. Scarborough RM, Naughton MA, Teng W, Hung DT, Rose J, et al. (1992) Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem 267: 13146-13149.
14. Russo A, Soh UJ, Trejo J (2009) Proteases display biased agonism at protease-activated receptors: location matters! Mol Interv 9: 87-96.
15. Reiser J, Adair B, Reinheckel T (2010) Specialized roles for cysteine cathepsins in health and disease. J Clin Invest 120: 3421-3431.
16. Storm van's Gravesande K, Layne MD, Ye Q, Le L, Baron RM, et al. (2002) IFN regulatory factor-1 regulates IFN-gamma-dependent cathepsin S expression. J Immunol 168: 4488-4494.
17. Riese RJ, Wolf PR, Bromme D, Natkin LR, Villadangos JA, et al. (1996) Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4: 357-366. (Pubitemid 26174051)
18. Ruckrich T, Brandenburg J, Cansier A, Muller M, Stevanovic S, et al. (2006) Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain. Biol Chem 387: 1503-1511. (Pubitemid 44691433)
19. Xin XQ, Gunesekera B, Mason RW (1992) The specificity and elastinolytic activities of bovine cathepsins S and H. Arch Biochem Biophys 299: 334-339. (Pubitemid 23029039)
20. Cattaruzza F, Lyo V, Jones E, Pham D, Hawkins J, et al. (2011) Cathepsin S is activated during colitis and causes visceral hyperalgesia by a PAR2-dependent mechanism in mice. Gastroenterology 141: 1864-1874 e1861-1863.
21. Hwang HS, Chung HS (2002) Preparation of active recombinant cathepsin K expressed in bacteria as inclusion body. Protein Expr Purif 25: 541-546.
22. Tobbell DA, Middleton BJ, Raines S, Needham MR, Taylor IW, et al. (2002) Identification of in vitro folding conditions for procathepsin S and cathepsin S using fractional factorial screens. Protein Expr Purif 24: 242-254. (Pubitemid 40047441)
23. Liu H, Sadygov RG, Yates JR 3rd (2004) A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 76: 4193-4201. (Pubitemid 38943698)
24. Washburn MP, Wolters D, Yates JR 3rd (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19: 242-247. (Pubitemid 32220565)
25. Biniossek ML, Nagler DK, Becker-Pauly C, Schilling O (2011) Proteomic identification of protease cleavage sites characterizes prime and non-prime specificity of cysteine cathepsins B, L, and S. J Proteome Res 10: 5363-5373.
26. Briot A, Lacroix M, Robin A, Steinhoff M, Deraison C, et al. (2010) Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model. J Invest Dermatol 130: 2736-2742.
27. Buddenkotte J, Stroh C, Engels IH, Moormann C, Shpacovitch VM, et al. (2005) Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B. J Invest Dermatol 124: 38-45. (Pubitemid 40100946)
28. Steinhoff M, Corvera CU, Thoma MS, Kong W, McAlpine BE, et al. (1999) Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 8: 282-294. (Pubitemid 29370853)
29. Ramachandran R, Mihara K, Mathur M, Rochdi MD, Bouvier M, et al. (2009) Agonist-biased signaling via proteinase activated receptor-2: differential activation of calcium and mitogen-activated protein kinase pathways. Mol Pharmacol 76: 791-801.
30. Ramachandran R, Sadofsky LR, Xiao Y, Botham A, Cowen M, et al. (2007) Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4. Am J Physiol Lung Cell Mol Physiol 292: L788-798. (Pubitemid 46376997)
31. Oikonomopoulou K, Hansen KK, Saifeddine M, Tea I, Blaber M, et al. (2006) Proteinase-activated receptors, targets for kallikrein signaling. J Biol Chem 281: 32095-32112. (Pubitemid 46036764)
32. Ramachandran R, Eissa A, Mihara K, Oikonomopoulou K, Saifeddine M, et al. (2012) Proteinase-activated receptors (PARs): differential signalling by kallikrein-related peptidases KLK8 and KLK14. Biol Chem 393: 421-427.
33. Ramachandran R, Noorbakhsh F, Defea K, Hollenberg MD (2012) Targeting proteinase-activated receptors: therapeutic potential and challenges. Nat Rev Drug Discov 11: 69-86.
34. Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, et al. (2007) Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 320: 1-13. (Pubitemid 46025713)
35. Oldham WM, Hamm HE (2008) Heterotrimeric G protein activation by G-protein-coupled receptors. Nat Rev Mol Cell Biol 9: 60-71.
36. Oldham WM, Van Eps N, Preininger AM, Hubbell WL, Hamm HE (2007) Mapping allosteric connections from the receptor to the nucleotide-binding pocket of heterotrimeric G proteins. Proc Natl Acad Sci U S A 104: 7927-7932. (Pubitemid 47185853)
37. Liu Q, Weng HJ, Patel KN, Tang Z, Bai H, et al. (2011) The distinct roles of two GPCRs, MrgprC11 and PAR2, in itch and hyperalgesia. Sci Signal 4: ra45.
38. Schwarz G, Boehncke WH, Braun M, Schroter CJ, Burster T, et al. (2002) Cathepsin S activity is detectable in human keratinocytes and is selectively upregulated upon stimulation with interferon-gamma. J Invest Dermatol 119: 44-49. (Pubitemid 35304389)